AU780840C - Methods for identifying combinations of entities as therapeutics - Google Patents

Methods for identifying combinations of entities as therapeutics

Info

Publication number
AU780840C
AU780840C AU54077/01A AU5407701A AU780840C AU 780840 C AU780840 C AU 780840C AU 54077/01 A AU54077/01 A AU 54077/01A AU 5407701 A AU5407701 A AU 5407701A AU 780840 C AU780840 C AU 780840C
Authority
AU
Australia
Prior art keywords
therapeutics
entities
methods
identifying combinations
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU54077/01A
Other versions
AU5407701A (en
AU780840B2 (en
Inventor
Alexis Borisy
Michael A. Foley
Brent R. Stockwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zalicus Inc
Original Assignee
CombinatoRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/009218 external-priority patent/WO2000061724A2/en
Application filed by CombinatoRx Inc filed Critical CombinatoRx Inc
Priority to AU54077/01A priority Critical patent/AU780840C/en
Publication of AU5407701A publication Critical patent/AU5407701A/en
Application granted granted Critical
Publication of AU780840B2 publication Critical patent/AU780840B2/en
Priority to AU2005203184A priority patent/AU2005203184B2/en
Publication of AU780840C publication Critical patent/AU780840C/en
Assigned to ZALICUS INC. reassignment ZALICUS INC. Request to Amend Deed and Register Assignors: COMBINATORX, INCORPORATED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU54077/01A 2000-04-06 2001-06-27 Methods for identifying combinations of entities as therapeutics Ceased AU780840C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU54077/01A AU780840C (en) 2000-04-06 2001-06-27 Methods for identifying combinations of entities as therapeutics
AU2005203184A AU2005203184B2 (en) 2000-04-06 2005-07-21 Methods for identifying combinations of entities as therapeutics

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2000/009218 WO2000061724A2 (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions
US61183500A 2000-07-07 2000-07-07
US09/611835 2000-07-07
AU54077/01A AU780840C (en) 2000-04-06 2001-06-27 Methods for identifying combinations of entities as therapeutics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005203184A Division AU2005203184B2 (en) 2000-04-06 2005-07-21 Methods for identifying combinations of entities as therapeutics

Publications (3)

Publication Number Publication Date
AU5407701A AU5407701A (en) 2002-01-10
AU780840B2 AU780840B2 (en) 2005-04-21
AU780840C true AU780840C (en) 2006-02-23

Family

ID=39595585

Family Applications (2)

Application Number Title Priority Date Filing Date
AU54077/01A Ceased AU780840C (en) 2000-04-06 2001-06-27 Methods for identifying combinations of entities as therapeutics
AU2005203184A Ceased AU2005203184B2 (en) 2000-04-06 2005-07-21 Methods for identifying combinations of entities as therapeutics

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2005203184A Ceased AU2005203184B2 (en) 2000-04-06 2005-07-21 Methods for identifying combinations of entities as therapeutics

Country Status (1)

Country Link
AU (2) AU780840C (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374536A (en) * 1991-03-18 1994-12-20 Nalco Chemical Company Synergistic product selection test for biocides
US5756304A (en) * 1995-07-14 1998-05-26 Molecular Solutions Screening of microorganisms for bioremediation
WO1998057174A1 (en) * 1997-06-09 1998-12-17 Nce Pharmaceuticals,Inc. Synthetic antibiotics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374536A (en) * 1991-03-18 1994-12-20 Nalco Chemical Company Synergistic product selection test for biocides
US5756304A (en) * 1995-07-14 1998-05-26 Molecular Solutions Screening of microorganisms for bioremediation
WO1998057174A1 (en) * 1997-06-09 1998-12-17 Nce Pharmaceuticals,Inc. Synthetic antibiotics

Also Published As

Publication number Publication date
AU5407701A (en) 2002-01-10
AU2005203184A1 (en) 2005-08-18
AU2005203184B2 (en) 2008-07-03
AU780840B2 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
AU2001269939A1 (en) Methods for eliminating the formation of biofilm
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001296436A1 (en) Methods for graphically representing interactions among entities
AUPQ496500A0 (en) Kit
AU2002222172A1 (en) Method of retrieving entities
AU2557500A (en) Methods of making compounds
AU2002216087A1 (en) Novel substituted imidazotriazinones as pde ii-inhibitors
AU2002361623A1 (en) Methods and compositions for chromatography
AUPS078002A0 (en) Dnazyme therapeutics
AUPR217700A0 (en) Methods for purification of lactose
IL144049A0 (en) Methods for identifying combinations of entities as therapeutics
AU2001281322A1 (en) Methods of identifying renal protective factors
AU2001241098A1 (en) Composition
AU2001285252A1 (en) Analysis of binding interactions
AU2001277815A1 (en) Method to determine the quality of eye-optics
AU2002223761A1 (en) Thickening composition
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2001213451A1 (en) Method for preparation of polycarbonates
AU2001237694A1 (en) Extension kit for calipers
AU2001266176A1 (en) Methods
AU2001275201A1 (en) Acne-treating composition
AU2002224835A1 (en) Dihydroisoquinolines as novel phosphodiesterase inhibitors
AU2002246676A1 (en) Methods for determining organisms
AU2001287852A1 (en) Composition
AU2001251004A1 (en) Detection of viable agents